DOI QR코드

DOI QR Code

The Correlation Between Left Ventricular Failure and Right Ventricular Systolic Dysfunction Occurring in Thyrotoxicosis

  • Hong, Ji-Yeon (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Park, Dae-Gyun (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Yoo, Jong-Jin (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Lee, Seung-Min (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Kim, Min-Kwan (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Kim, Sung-Eun (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Lee, Jun-Hee (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Han, Kyoo-Rok (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Oh, Dong-Jin (Department of Internal Medicine, Hallym University College of Medicine)
  • Received : 2009.08.12
  • Accepted : 2009.09.30
  • Published : 2010.06.30

Abstract

Background and Objectives: Heart failure rarely occurs in patients with thyrotoxicosis (6%), with half of the cases having left ventricular dysfunction (LVD). Although a few studies reported isolated right heart failure in thyrotoxicosis, there has been no evaluation of relationship between LVD and right ventricular dysfunction (RVD). Subjects and Methods: We enrolled 12 patients (mean age: 51${\pm}$11 years, 9 females) diagnosed as having thyrotoxicosis with heart failure and LVD {left ventricular ejection fraction (LVEF) <40%}, and divided them into two groups {Group I with RVD defined as tricuspid annular plane excursion (TAPSE) less than 15 mm and Group II without RVD}. Clinical features, laboratory variables, and echocardiographic parameters were compared between two groups. Results: RVD was found in 6 (50%) patients. On admission, there were no significant differences between the two groups in clinical features, laboratory variables, or echocardiographic parameters including atrial fibrillation {6 vs. 5, not significant (NS)}, heart rate (149${\pm}$38 vs. 148${\pm}$32/min, NS), LVEF (36.7${\pm}$9.5 vs. 35.1${\pm}$6.3%, NS), or the tricuspid regurgitation peak pressure gradient (TRPPG, 30.9${\pm}$2.0 vs. 36.3${\pm}$9.3 mmHg, NS). After antithyroid treatment, all achieved an euthyroid state and both ventricular functions were recovered. All data, including the recovery time of LVEF and the change of heart rate between two groups, displayed no significant differences. Conclusion: In half of patients, RVD was combined with thyrotoxicosis-associated LVD. There were no differences in clinical factors or hemodynamic parameters between patients with and without RVD. This suggests that RVD is not secondary to thyrotoxicosis-associated LVD.

Keywords

References

  1. Dahl P, Danzi S, Kein I. Thyrotoxic cardiac disease. Curr Heart Fail Rep 2008;5:170-6. https://doi.org/10.1007/s11897-008-0026-9
  2. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-9. https://doi.org/10.1056/NEJM200102153440707
  3. Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med 2003;114:51-5. https://doi.org/10.1016/S0002-9343(02)01472-9
  4. Siu CW, Yeung CY, Lau CP, Kung A, Tse HF. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart 2007;93:483-7. https://doi.org/10.1136/hrt.2006.100628
  5. Di Giovambattista R. Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure. Cardiovasc Ultrasound 2008;6:29. https://doi.org/10.1186/1476-7120-6-29
  6. Lozano HF, Sharma CN. Reversible pulmonary hypertension, tricuspid regurgitation and right-sided heart failure associated with hyperthyroidism: case report and review of the literature. Cardiol Rev 2004;12:299-305. https://doi.org/10.1097/01.crd.0000137259.83169.e3
  7. Cohen J, Schattner A. Right heart failure and hyperthyroidism: a neglected presentation. Am J Med 2003;115:76-7. https://doi.org/10.1016/S0002-9343(03)00288-2
  8. Park JH, Shong MH, Lee JH, Choi SW, Jeoung JO, Seong IW. Reversible severe tricuspid regurgitation with right heart failure associated with thyrotoxicosis. Thyroid 2006;16:813-4. https://doi.org/10.1089/thy.2006.16.813
  9. Lozano HF, Sharma CN. Reversible pulmonary hypertension, tricuspid regurgitation and right-sided heart failure associated hyperthyroidism: case report and review of the literature. Cardiol Rev 2004;12:299-305. https://doi.org/10.1097/01.crd.0000137259.83169.e3
  10. Nakchbandi I, Wirth J, Inzucchi S. Pulmonary hypertension caused by Graves' thyrotoxicosis: normal pulmonary hemodynamics restored by (131)I treatment. Chest 1999;116:1483-5. https://doi.org/10.1378/chest.116.5.1483
  11. Syrius V, Plastiras SC, Paterakis T, Moyssakis I, Vlachoyiannopoulos P. Severe reversible right heart failure in a patient with hyperthyroidism. Int J Clin Pract 2008;62:334-6. https://doi.org/10.1111/j.1742-1241.2006.00979.x
  12. Kang B, Cho DK, Byun KH, Eun LY, Cho YH. Isolated pulmonary arterial hypertension-Janus' faces of hyperthyroidism. Korean Circ J 2009;39:168-70. https://doi.org/10.4070/kcj.2009.39.4.168
  13. Pereira N, Parisi A, Dec GW, Choo J, Hajjar R, Gordon PC. Myocardial stunning in hyperthyroidism. Clin Cardiol 2000;23:298-300. https://doi.org/10.1002/clc.4960230417
  14. Kwak JJ, Choi YJ, Kwon KH, Park SH. A case of myocardial stunning in hyperthyroidism. Korean Circ J 2004;34:516-9. https://doi.org/10.4070/kcj.2004.34.5.516
  15. Kiss E, Jakab G, Kranias EG, Edes I. Thyroid hormone-induced alterations in phospholamban protein expression: regulatory effects on sarcoplasmic reticulum $Ca^{2+}$ transport and myocardial relaxation. Circ Res 1994;75:245-51. https://doi.org/10.1161/01.RES.75.2.245
  16. Garcia-Gonzalez MJ, Dominguez-Rodriguez A, Garcia CR. Acute right ventricular dysfunction after cardioversion or hyperthyroid cardiomyopathy in an unrecognized thyrotoxicosis patient? Am J Emerg Med 2007;25:723-4. https://doi.org/10.1016/j.ajem.2006.11.036

Cited by

  1. A Rapid Improvement of Heart Failure after Treatment of Hyperthyroidism vol.1, pp.2, 2010, https://doi.org/10.12997/jla.2012.1.2.101
  2. Right ventricular dysfunction and pulmonary hypertension: a neglected presentation of thyrotoxicosis vol.2018, pp.None, 2010, https://doi.org/10.1530/edm-18-0012